Greg is a partner within the corporate and commercial team. He has a wealth of experience advising on a wide range of corporate transactions with a focus on domestic and international M&A, advising investor and investee companies on private equity investments, particularly in the life science sector. Greg’s clients include Development Bank of Wales, Creo Medical and FP Hurley. He has acted as the lead on a number of standout corporate transactions including Voltcom on its reorganisation and multimillion pound investment by Beechbrook Capital and sale of Amber Engineering of Biffa Plc.
Greg also leads the dedicated healthcare team. He is highly regarded within this sector as has a wealth of experience acting for the healthcare and the life sciences businesses. Greg has forged his reputation through his knowledge and expertise working on some complex, high-value transactions including advising Sheppard Pharmacy, the largest independent pharmacy group in Wales, on its acquisitions including the recent purchases of Emersons Pharmacy and Hope Pharmacy. He also advised Minerva Laboratories in their management buy-out.
Greg regularly speaks at seminars on topics such as succession planning and management buy-outs, private equity investments with a specific focus on the pharmaceutical sector.
Work History
Greg became a partner in 2012 after joining Hugh James in 2008 as a senior associate. He has since acted as lead contact on a number of corporate transactions.
Greg qualified in 2001 and has exclusively advised on corporate and M&A matters.